ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,572Medicare Part D Prescriptions Filled, Including Refills

Rank: 190 out of 1278

$1.1M Total Retail Price of All Prescriptions

Rank: 12 out of 1278

250 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 250 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 250 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 5,883 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$145 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 277 277 1 2
WARFARIN SODIUM 266 244 2 17
LISINOPRIL 261 225 3 1
TRAZODONE HCL 189 114 4 38
FUROSEMIDE 187 183 5 10
DONEPEZIL HCL 182 182 6 48
LIDODERM 166 159 7 165
GABAPENTIN 152 125 8 12
OMEPRAZOLE 151 113 9 6
METOPROLOL TARTRATE 146 135 10 9
SERTRALINE HCL 129 128 11 28
NORVIR 118 0 12 109
ISENTRESS 116 21 13 125
HYDROCODONE-ACETAMINOPHEN 113 106 S3 14 7
MIRTAZAPINE 107 93 15 86
KLOR-CON M20 100 99 16 117
POTASSIUM CHLORIDE 91 81 17 21
CYMBALTA 88 57 18 67
TRUVADA 87 13 19 115
RANITIDINE HCL 86 63 20 20
NAMENDA 86 86 20 77
QUETIAPINE FUMARATE 80 80 22 126
AMLODIPINE BESYLATE 79 79 23 5
POLYETHYLENE GLYCOL 3350 77 70 24 105
METFORMIN HCL 75 65 25 4
PREDNISONE 73 72 26 52
OXYCODONE HCL 72 51 S2 27 27
IPRATROPIUM-ALBUTEROL 71 71 28 176
MELOXICAM 71 70 28 57
PAROXETINE HCL 69 64 30 56
ESCITALOPRAM OXALATE 68 68 31 134
FLUTICASONE PROPIONATE 67 40 32 24
ATENOLOL 67 67 32 11
CITALOPRAM HBR 66 37 34 22
DILTIAZEM 24HR CD 65 65 35 133
ATORVASTATIN CALCIUM 61 37 36 15
FENTANYL 59 53 S2 37 97
REYATAZ 56 0 38 170
DIVALPROEX SODIUM 55 34 39 140
SIMVASTATIN 54 53 40 3
ROPINIROLE HCL 54 47 40 127
TRAMADOL HCL 54 51 40 25
PREZISTA 53 0 43 163
OXYCONTIN 53 27 S2 43 89
CARBIDOPA-LEVODOPA 52 49 45 141
OXYCODONE-ACETAMINOPHEN 52 40 S2 45 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.